Ritucad 100 mg Injection
$104,26
$32,98
Ritucad 100 mg injection is a powerful monoclonal antibody designed to target and modulate the immune system, making it an essential option for patients battling specific types of cancer, such as non-Hodgkin's lymphoma and chronic lymphocytic leukemia. By selectively binding to cancerous cells, Ritucad helps inhibit their growth and promotes a more robust immune response, effectively aiding in the management of these challenging conditions. Patients receiving this treatment should be monitored for potential side effects, which may include infusion reactions and infections, necessitating close observation by healthcare providers. Additionally, it is crucial to inform your doctor about any existing health issues or medications prior to starting Ritucad to avoid adverse interactions. As an integral part of targeted cancer therapy, Ritucad 100 mg injection offers a promising avenue for improving patient outcomes and enhancing quality of life. With its unique mechanism of action, this injection not only addresses cancer directly but also works to empower the body’s natural defenses. Always discuss with your healthcare professional to ensure that Ritucad is the right choice for your treatment plan. Embracing advancements in immunotherapy, Ritucad continues to pave the way for innovative cancer care.
數量
Active Pharmaceutical Ingredient
Uses
• Ritucad 100 mg injection is primarily used in the treatment of non-Hodgkin lymphoma (NHL). This type of cancer affects the lymphatic system, and Ritucad helps to target and destroy malignant cells. Patients receiving this treatment may experience improved outcomes in managing their condition. The injection is typically administered in a healthcare setting under medical supervision.
• In addition to NHL, Ritucad 100 mg injection is effective for patients with chronic lymphocytic leukaemia (CLL). CLL is a type of blood cancer that affects the white blood cells, and Ritucad assists in controlling the disease progression. By targeting specific proteins on cancer cells, this medication can help improve the overall health and quality of life for individuals diagnosed with CLL. Regular monitoring during treatment is essential to assess effectiveness.
• Ritucad 100 mg injection is also indicated for the management of rheumatoid arthritis, a chronic inflammatory condition. This medication works by modulating the immune system to reduce inflammation and joint damage. Patients often find that Ritucad helps alleviate symptoms and improves their ability to perform daily activities. It is usually part of a comprehensive treatment plan tailored to individual needs.
• Another significant use of Ritucad 100 mg injection is in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis. These are serious autoimmune conditions that cause inflammation of blood vessels. Ritucad helps to suppress the immune response, thereby reducing inflammation and preventing damage to vital organs. This targeted approach can lead to better management of symptoms and improved patient outcomes.
Benefits
Non-Hodgkin lymphoma (NHL): Non-Hodgkin's lymphoma is a form of cancer that affects the white blood cells in the body. These cells are responsible for preventing infections. Ritucad 100 mg Injection has been demonstrated to reduce the immune response and relieve pain and inflammation. It also can kill cancer cells and prevent their further growth. To prevent the spread of infection, it is advisable to avoid crowds and to wash your hands frequently. It is recommended that patients consume an adequate quantity of fluids unless otherwise advised by their physician.
Rheumatoid arthritis: Ritucad 100 mg is an immunosuppressant that is used to treat rheumatoid arthritis. It is administered in a dose and frequency that is tailored to the patient's condition. This is determined by the physician. It is crucial to adhere to the physician's instructions and to promptly report any adverse effects, including fever, chills, or other symptoms, to the physician.
Blood cancer (chronic lymphocytic leukemia): Leukemia, also known as blood cancer, is a malignant neoplasm of the hematopoietic tissues that impairs the body's ability to combat infection. Ritucad 100 Injection is a chemotherapeutic agent that kills or inhibits the proliferation of malignant cells and is effective in the treatment of leukemia. However, it is important to discuss the potential side effects and benefits of this medication with a qualified healthcare professional. It is also essential to inform your doctor of any adverse effects that may arise during treatment.
Granulomatosis with polyangiitis: Granulomatosis with polyangiitis (GPA) is a condition that causes inflammation of the blood vessels of the ears, nose, throat, lungs, and kidneys. In this condition, the blood flow to these areas may be reduced, which can lead to their damage. Ritucad 100 mg Injection is an effective treatment that helps reduce inflammation, pain, and swelling and prevents further damage. This improves the quality of life of those affected by GPA.
Microscopic polyangiitis: Microscopic polyangiitis is an autoimmune disease that affects the small blood vessels and may be caused by an imbalance in the immune system. Ritucad 100 mg Injection reduces the immune response and improves inflammation. This helps to heal the condition and to alleviate discomfort.
Side Effects
Ritucad 100 mg Injection can cause various adverse effects that can differ from one person to another. Some of the adverse effects of the drug are listed below.
Most Common Side Effects
• Low Immunity
• Nausea
• Tinnitus
• Muscle Pain and Stiffness
• Face Swelling
• Low Blood Count of White Blood Cells and Red Blood Cells
• Increase in Glucose Levels in Blood
• Headache
Common Side Effects
• Skin Reactions
• Heart Problems
• Infections
• Allergies
How To Use
The administration of Ritucad 100 Injection is typically conducted by a medical professional, such as a doctor or nurse, in a medical facility, such as a hospital or clinic. It is not advisable to administer the product independently, and it is important to adhere to the instructions provided by a qualified healthcare professional.
Safety Advice
• Alcohol: Caution should be exercised when drinking alcohol with Ritucad 100 mg. Please consult your doctor.
• Kidney: Ritucad 100 mg Injection is likely to be safe in patients with kidney disease. The limited data available suggest that dose adjustment of Vortuxi Solution for Infusion may not be necessary for these patients. Please consult your doctor.
• Breastfeeding: Ritucad 100 mg Injection is likely to be safe to use while breastfeeding, and limited human statistics support that the drug now no longer poses a good risk to the baby.
• Liver: Ritucad 100 mg Injection is not recommended in patients with active liver disease or those who have had viral hepatitis. Please consult your doctor.
• Pregnancy: Ritucad 100 mg Injection may not be safe for use during pregnancy. Although there is limited human research, animal research has shown dangerous effects on the growing baby. Your doctor will weigh up the benefits and potential risks before prescribing it to you. Please consult your doctor.
• Driving: It is not known whether Ritucad 100 mg affects your ability to drive. Do not drive if you experience symptoms that affect your ability to concentrate and react.